1 – 10 of 3194
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Galectin 3 : A new player in the pathogenesis of Parkinson's disease
- Contribution to journal › Article
- 2025
-
Mark
GDNF overexpression in astrocytes enhances branching and partially preserves hippocampal function in an Alzheimer's rat model
- Contribution to journal › Article
-
Mark
Lack of neuroprotection after systemic administration of the soluble TNF inhibitor XPro1595 in an rAAV6-α-Syn + PFFs-induced rat model for Parkinson's disease
- Contribution to journal › Article
-
Mark
Impact of tyrosine amination on the aggregation and neurotoxicity of amyloid-β
- Contribution to journal › Article
-
Mark
Autologous cells, no longer lost in translation
- Contribution to journal › Debate/Note/Editorial
-
Mark
Neurophysiological Treatment Effects of Mesdopetam, Pimavanserin and Amantadine in a Rodent Model of Levodopa-Induced Dyskinesia
- Contribution to journal › Article
-
Mark
Genome-Wide Association Study Meta-Analysis of 9619 Cases With Tic Disorders
- Contribution to journal › Article
-
Mark
Mapping grey and white matter activity in the human brain with isotropic ADC-fMRI
- Contribution to journal › Article
-
Mark
TDP-43 overexpression in the hypothalamus drives neuropathology, dysregulates metabolism and impairs behavior in mice
- Contribution to journal › Article
-
Mark
Molecular treatments to reduce catabolic effects in human meniscus explant models
- Contribution to journal › Article
